CellCyte CEO Fraud Claims Can Move Forward
CellCyte Genetics Corp.'s former CEO has lost his bid to throw out U.S. Securities and Exchange Commission claims related to allegedly fraudulent statements that inflated the company's stock price, but the...To view the full article, register now.
Already a subscriber? Click here to view full article